Cargando…
Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
Recent evidence suggests that Alzheimer's disease (AD) and depression share common mechanisms of pathogenesis. In particular, deregulation of glutamate-mediated excitatory signaling may play a role in brain dysfunction in both AD and depression. We have investigated levels of glutamate and its...
Autores principales: | Madeira, Caroline, Vargas-Lopes, Charles, Brandão, Carlos Otávio, Reis, Taylor, Laks, Jerson, Panizzutti, Rogerio, Ferreira, Sergio T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232456/ https://www.ncbi.nlm.nih.gov/pubmed/30459657 http://dx.doi.org/10.3389/fpsyt.2018.00561 |
Ejemplares similares
-
Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
por: Madeira, Caroline, et al.
Publicado: (2018) -
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome
por: Guerrero-Molina, María Paz, et al.
Publicado: (2022) -
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
por: Hashimoto, Kenji, et al.
Publicado: (2005) -
Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia
por: Bustillo, Juan R., et al.
Publicado: (2017) -
Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
por: Guercio, Gerson D., et al.
Publicado: (2018)